Validation of a patient‐reported outcomes symptom measure for patients with nontransfusion‐dependent thalassemia (NTDT‐PRO(©))

This study demonstrates the quantitative characteristics of the first patient‐reported outcome (PRO) tool developed for patients with nontransfusion‐dependent β‐thalassemia (NTDT), the NTDT‐PRO(©). A multicenter validation study was performed over 24 weeks, involving 48 patients from Italy, Lebanon,...

Descripción completa

Detalles Bibliográficos
Autores principales: Taher, Ali, Cappellini, Maria Domenica, Viprakasit, Vip, Sutcharitchan, Pranee, Mahmoud, Dalia, Laadem, Abderrahmane, Khan, Anzalee, Gwaltney, Chad, Harding, Gale, Attie, Kenneth, Zhang, Xiaosha, Zou, Jun, Pariseau, Joseph, Henry Hu, X., Kattamis, Antonis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587834/
https://www.ncbi.nlm.nih.gov/pubmed/30394570
http://dx.doi.org/10.1002/ajh.25344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587834/
https://www.ncbi.nlm.nih.gov/pubmed/30394570
http://dx.doi.org/10.1002/ajh.25344

Ejemplares similares